ArticleThe Pan African medical journal2026
[Epidemiology of HIV, hepatitis B, and hepatitis C infections and priority interventions for the elimination of Hepatitis B: a study in the Far North Region of Cameroon].
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: with the aim of guiding the strategic response to major viral infections, this study aimed to determine the epidemiological profile of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) in the Far North region of Cameroon. Methods: we conducted a cross-sectional epidemiological surveillance study in the Mayo-Tsanaga Division and surrounding localities in the Far North region of Cameroon from August 1 to September 20, 2024. After obtaining informed consent, each participant was given a standard questionnaire and tested for the three infections (HIV, HBV, and HCV) in accordance with the national testing algorithm. The collected data were analyzed using Excel 2019 and Power BI software, with a statistical significance threshold set at p < 0.05. Results: a total of 3,188 participants were tested (60% female, median age 34 years [IQR 20-46]), of whom 396 tested positive overall, including 13 who were HIV-positive, 373 who were HBV-positive, and 10 who were HCV-positive. According to each type of infection, HIV, HBV and HCV seropositivity rates were 0.41% (13/3,170), 11.7% (373/3,188) and 0.31% (10/3,188), respectively. Despite the high endemicity of HBV (>8%), no statistically significant differences were observed by age or sex (p > 0.05). Conclusion: the low prevalence rates (<1%) of HIV and HCV suggest that their elimination is effectively underway among populations in the Far North region of Cameroon. However, the high endemicity of HBV indicates ongoing transmission and underscores the urgent need to prioritize vaccination as the primary preventive intervention toward elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.